Overview


We are one of the leading providers of worldwide manufacturing services and
solutions. We provide comprehensive electronics design, production and product
management services to companies in various industries and end markets. Our
services enable our customers to reduce manufacturing costs, improve
supply-chain management, reduce inventory obsolescence, lower transportation
costs and reduce product fulfillment time. Our manufacturing and supply chain
management services and solutions include innovation, design, planning,
fabrication and assembly, delivery and managing the flow of resources and
products. We derive substantially all of our revenue from production and product
management services (collectively referred to as "manufacturing services"),
which encompass the act of producing tangible components that are built to
customer specifications and are then provided to the customer.

We serve our customers primarily through dedicated business units that combine
highly automated, continuous flow manufacturing with advanced electronic design
and design for manufacturability. We depend, and expect to continue to depend,
upon a relatively small number of customers for a significant percentage of our
net revenue, which in turn depends upon their growth, viability and financial
stability. Based on net revenue, for the nine months ended May 31, 2020, our
largest customers include Amazon.com, Inc., Apple, Inc., Cisco Systems, Inc.,
Hewlett-Packard Company, Ingenico Group, Johnson and Johnson, LM Ericsson
Telephone Company, NetApp, Inc., SolarEdge Technologies Inc., and Tesla, Inc.

We conduct our operations in facilities that are located worldwide, including
but not limited to, China, Malaysia, Mexico, Singapore, the United States and
Vietnam. We derived a substantial majority, 83.4% and 82.6%, of net revenue from
our international operations for the three months and nine months ended May 31,
2020. Our global manufacturing production sites allow customers to manufacture
products simultaneously in the optimal locations for their products. Our global
presence is key to assessing and executing on our business opportunities.

We have two reporting segments: Electronics Manufacturing Services ("EMS") and
Diversified Manufacturing Services ("DMS"), which are organized based on the
economic profiles of the services performed, including manufacturing
capabilities, market strategy, margins, return on capital and risk profiles. Our
EMS segment is focused around leveraging IT, supply chain design and
engineering, technologies largely centered on core electronics, utilizing our
large scale manufacturing infrastructure and our ability to serve a broad range
of end markets. Our EMS segment is a high volume business that produces product
at a quicker rate (i.e. cycle time) and in larger quantities and includes
customers primarily in the automotive and transportation, capital equipment,
cloud, computing and storage, defense and aerospace, industrial and energy,
networking and telecommunications, print and retail, and smart home and
appliances industries. Our DMS segment is focused on providing engineering
solutions, with an emphasis on material sciences, technologies and healthcare.
Our DMS includes customers primarily in the edge devices and accessories,
healthcare, mobility and packaging industries.

We monitor the current economic environment and its potential impact on both the
customers we serve as well as our end-markets and closely manage our costs and
capital resources so that we can respond appropriately as circumstances change.

The COVID-19 pandemic, which began to impact us in January 2020, has continued
to affect our business and the businesses of our customers and suppliers into
our fiscal third quarter. Travel and business operation restrictions arising
from virus containment efforts of governments around the world have continued to
impact our operations in Asia, Europe and the Americas. With the exception of
certain jurisdictions, essential activity exceptions from these restrictions
have allowed us to continue to operate. Nevertheless, virus containment efforts
in the three and nine months ended May 31, 2020, led to a disruption in
operations and certain facility or intermittent business closures in areas such
as China, Malaysia, India and California, which have resulted in additional
direct costs and a reduction in revenue in certain end markets. Our first
priority has been the health and safety of our employees and so we have incurred
additional costs in order to procure the necessary equipment, including face
masks, thermometers, hand sanitizers and personal protection equipment, to keep
our employees safe. We have implemented risk-mitigation activities including
travel restrictions, social distancing practices, additional cleaning procedures
within our facilities, contact tracing, COVID-19 testing, and requiring
employees and visitors to have their temperatures taken and wear masks when they
are at our sites. During the three months and nine months ended May 31, 2020, we
incurred approximately $67.4 million and $120.4 million, respectively, in direct
costs associated with the COVID-19 outbreak, primarily due to incremental and
idle labor costs leading to a reduction in factory utilization as a result of
the travel disruptions and governmental restrictions and the procurement of
personal protection equipment for our employees globally.

Additionally, certain of the Company's suppliers were similarly impacted by the
COVID-19 pandemic, leading to supply chain constraints, including difficulty
sourcing materials necessary to fulfill customer production requirements and
challenges in transporting completed products to our end customers.

                                       28

--------------------------------------------------------------------------------

Table of Contents




We have implemented efforts across the organization to enhance our financial
position, increase liquidity and reduce costs. During the three months ended May
31, 2020, we added incremental short-term committed revolving credit agreements
of $625.0 million.

In addition, we have taken aggressive steps to reduce expenses, including
suspending base salary increases for Fiscal Year 2021. Our Chief Executive
Officer, Chief Financial Officer and other executive vice presidents will reduce
their base salaries by 25% from June 1, 2020 through November 30, 2020 and will
forego any bonus that would otherwise be due to them under Jabil's Fiscal Year
2020 short-term incentive program. Members of Jabil's Board of Directors will
also reduce by 25% their annual cash retainers that would otherwise be payable
during the period from June 1, 2020 through November 30, 2020.

In order to further decrease operating expenses and better align with the needs
of the business, we have reduced our worldwide workforce and implemented
voluntary early retirement programs. In connection with reducing our worldwide
workforce, we incurred $52.3 million of severance and benefit costs during the
three and nine months ended May 31, 2020. Following this reduction in headcount,
we expect annual savings beginning in Fiscal Year 2021 of approximately $40.0
million to $50.0 million. We continue to focus on prioritizing spending related
to future business.

Our performance is subject to global economic conditions, as well as their
impacts on levels of consumer spending and the production of goods. These
current conditions are significantly impacted by COVID-19, have had a negative
impact on our results of operations during the three months and nine months
ended May 31, 2020 and will continue to have a negative impact on our operations
over the next fiscal quarter and likely beyond.

See Risk Factors, "The effect of COVID-19 on our operations and the operations
of our customers, suppliers and logistics providers has, and is expected to
continue to have, a material and adverse impact on our financial condition and
results of operations."
Summary of Results
The following table sets forth, for the periods indicated, certain key operating
results and other financial information (in thousands, except per share data):
                                        Three months ended                  Nine months ended
                                  May 31, 2020      May 31, 2019      May 31, 2020     May 31, 2019
Net revenue                      $  6,335,642     $    6,135,602     $ 19,966,423     $  18,708,867
Gross profit                     $    456,148     $      443,799     $  1,440,112     $   1,418,323
Operating income                 $     59,384     $      140,918     $    302,793     $     511,611
Net (loss) income attributable
to Jabil Inc.                    $    (50,958 )   $       43,482     $    (13,819 )   $     234,436
(Loss) earnings per share-basic  $      (0.34 )   $         0.28     $      (0.09 )   $        1.50
(Loss) earnings per
share-diluted                    $      (0.34 )   $         0.28     $      (0.09 )   $        1.47


Key Performance Indicators
Management regularly reviews financial and non-financial performance indicators
to assess the Company's operating results. Changes in our operating assets and
liabilities are largely affected by our working capital requirements, which are
dependent on the effective management of our sales cycle as well as timing of
payments. Our sales cycle measures how quickly we can convert our manufacturing
services into cash through sales. We believe the metrics set forth below are
useful to investors in measuring our liquidity as future liquidity needs will
depend on fluctuations in levels of inventory, accounts receivable and accounts
payable.
The following table sets forth, for the quarterly periods indicated, certain of
management's key financial performance indicators:

                                       29

--------------------------------------------------------------------------------


  Table of Contents

                                                     Three months ended
                                                  February    November
                                    May 31, 2020  29, 2020    30, 2019   August 31, 2019
Sales cycle(1)                           27 days     30 days     23 days         19 days
Inventory turns (annualized)(2)          5 turns     5 turns     6 turns         6 turns
Days in accounts receivable(3)           37 days     34 days     43 days         38 days
Days in inventory(4)                     67 days     70 days     57 days         58 days
Days in accounts payable(5)              77 days     74 days     77 days         77 days




(1) The sales cycle is calculated as the sum of days in accounts receivable and

days in inventory, less the days in accounts payable; accordingly, the

variance in the sales cycle quarter over quarter was a direct result of

changes in these indicators.

(2) Inventory turns (annualized) are calculated as 360 days divided by days in

inventory.

(3) Days in accounts receivable is calculated as accounts receivable, net,

divided by net revenue multiplied by 90 days. During the three months ended

May 31, 2020 and November 30, 2019, the increase in days in accounts

receivable from the prior sequential quarter was primarily due to an

increase in accounts receivable, primarily driven by higher sales and

timing of collections. During the three months ended February 29, 2020, the

decrease was primarily driven by lower sales and the timing of collections

in the second quarter.

(4) Days in inventory is calculated as inventory and contract assets divided by

cost of revenue multiplied by 90 days. During the three months ended May

31, 2020, the decrease was primarily due to increased sales activity during

the quarter. During the three months ended February 29, 2020, the increase

was primarily driven by idle capacity and supply chain constraints, largely


      in China due to COVID-19.


(5)   Days in accounts payable is calculated as accounts payable divided by cost
      of revenue multiplied by 90 days.



Critical Accounting Policies and Estimates
The preparation of our Condensed Consolidated Financial Statements and related
disclosures in conformity with U.S. generally accepted accounting principles
("U.S. GAAP") requires management to make estimates and judgments that affect
our reported amounts of assets and liabilities, revenues and expenses, and
related disclosures of contingent assets and liabilities. On an on-going basis,
we evaluate our estimates and assumptions based upon historical experience and
various other factors and circumstances. Management believes that our estimates
and assumptions are reasonable under the circumstances; however, actual results
may vary from these estimates and assumptions under different future
circumstances. For further discussion of our significant accounting policies,
refer to Note 1 - "Description of Business and Summary of Significant Accounting
Policies" to the Consolidated Financial Statements and "Management's Discussion
and Analysis of Financial Condition and Results of Operations - Critical
Accounting Policies and Estimates" in our Annual Report on Form 10-K for the
fiscal year ended August 31, 2019.
Recent Accounting Pronouncements
See Note 19 - "New Accounting Guidance" to the Condensed Consolidated Financial
Statements for a discussion of recent accounting guidance.
Results of Operations
Net Revenue
Generally, we assess revenue on a global customer basis regardless of whether
the growth is associated with organic growth or as a result of an acquisition.
Accordingly, we do not differentiate or separately report revenue increases
generated by acquisitions as opposed to existing business. In addition, the
added cost structures associated with our acquisitions have historically been
relatively insignificant when compared to our overall cost structure.
The distribution of revenue across our segments has fluctuated, and will
continue to fluctuate, as a result of numerous factors, including the following:
fluctuations in customer demand; efforts to diversify certain portions of our
business; business growth from new and existing customers; specific product
performance; and any potential termination, or substantial winding down, of

                                       30

--------------------------------------------------------------------------------

Table of Contents

significant customer relationships.


                              Three months ended                                Nine months ended
(dollars in millions)   May 31, 2020       May 31, 2019      Change      May 31, 2020       May 31, 2019      Change
Net revenue           $      6,335.6     $      6,135.6        3.3 %   $     19,966.4     $     18,708.9        6.7 %





Net revenue increased during the three months ended May 31, 2020, compared to
the three months ended May 31, 2019. Specifically, the DMS segment revenues
increased 13% due to (i) a 7% increase in revenues from new and existing
customers in our healthcare and packaging businesses, (ii) a 4% increase in
revenues from existing customers within our edge devices and accessories
business, and (iii) a 2% increase in revenues from existing customers within our
mobility business. The EMS segment revenues decreased 2% primarily due to (i) a
6% decrease from existing customers within our networking and telecommunications
business, (ii) a 3% decrease in revenues from existing customers within our
print and retail business, and (iii) a 4% decrease in revenues spread across
various industries within the EMS segment, including our smart home and
appliances and automotive and transportation businesses. The decrease is
partially offset by (i) an 8% increase in revenues from existing customers
within our cloud business and (ii) a 3% increase in revenues spread across
various industries within the EMS segment, including our capital equipment
business.
Net revenue increased during the nine months ended May 31, 2020, compared to the
nine months ended May 31, 2019. Specifically, the EMS segment revenues increased
8% primarily due to (i) a 13% increase in revenues from existing customers
within our cloud business and (ii) a 2% increase in revenues from existing
customers within our capital equipment business. The increase is partially
offset by a 7% decrease from existing customers within our networking and
telecommunications business. DMS segment revenues increased 5% due to a 12%
increase in revenues from new and existing customers in our healthcare and
packaging businesses. The increase is partially offset by a 7% decrease in
revenue from customers within our mobility and edge devices and accessories
businesses due to decreased end user product demand and end market dynamics in
the first quarter of fiscal year 2020.
The following table sets forth, for the periods indicated, revenue by segment
expressed as a percentage of net revenue:
            Three months ended               Nine months ended
      May 31, 2020     May 31, 2019    May 31, 2020     May 31, 2019
EMS          62 %             65 %            61 %               60 %
DMS          38 %             35 %            39 %               40 %
Total       100 %            100 %           100 %              100 %

The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue:


                             Three months ended               Nine months 

ended


                       May 31, 2020     May 31, 2019    May 31, 2020     May 31, 2019
Foreign source revenue       83.4 %            86.5 %         82.6 %            89.2 %


Gross Profit
                              Three months ended                  Nine months ended
(dollars in millions)   May 31, 2020      May 31, 2019     May 31, 2020      May 31, 2019
Gross profit           $      456.1      $      443.8     $     1,440.1     $     1,418.3
Percent of net revenue          7.2 %             7.2 %             7.2 %             7.6 %



Gross profit as a percentage of net revenue remained consistent for the three
months ended May 31, 2020, compared to the three months ended May 31, 2019.
During the three months ended May 31, 2020, we recognized $50.9 million in
incremental and idle labor costs associated with travel disruptions and
governmental restrictions, largely related to the COVID-19 outbreak.  This
increase in costs was partially offset by governmental subsidies, such as lower
payroll taxes or social insurance in certain countries, related to COVID-19
incentives. During the three months ended May 31, 2019, we had weakness in the
capital equipment business and ramp costs associated with new business awards.


                                       31

--------------------------------------------------------------------------------

Table of Contents



Gross profit as a percentage of net revenue decreased for the nine months ended
May 31, 2020, compared to the nine months ended May 31, 2019, primarily due to
an increase of $97.6 million in incremental and idle labor costs associated with
travel disruptions and governmental restrictions, largely related to the
COVID-19 outbreak. Additionally, gross profit as a percent of revenue decreased
for the EMS segment largely due to product mix. The decrease was partially
offset by an increase in the DMS segment due to improved profitability across
the various businesses.
Selling, General and Administrative
                             Three months ended                                 Nine months ended
(dollars in
millions)              May 31, 2020       May 31, 2019       Change       May 31, 2020      May 31, 2019       Change
Selling, general and
administrative       $     302.8         $       274.5     $   28.3     $   

916.8 $ 834.8 $ 82.0




Selling, general and administrative expenses increased during the three months
ended May 31, 2020, compared to the three months ended May 31, 2019. The
increase is predominantly due to (i) a $16.6 million increase in salary and
salary related expenses and other costs primarily due to our strategic
collaboration with a healthcare company, (ii) $16.5 million in costs related to
the COVID-19 outbreak, including personal protection equipment for our employees
globally and (iii) a $2.4 million increase in stock-based compensation expense.
The increase is partially offset by a $7.2 million decrease in acquisition and
integration charges related to our strategic collaboration with a healthcare
company.
Selling, general and administrative expenses increased during the nine months
ended May 31, 2020, compared to the nine months ended May 31, 2019. The increase
is predominantly due to (i) a $49.5 million increase in salary and salary
related expenses and other costs primarily due to our strategic collaboration
with a healthcare company, (ii) $22.8 million in costs related to the COVID-19
outbreak, including personal protection equipment for our employees globally and
(iii) a $14.7 million increase in stock-based compensation expense. The increase
is partially offset by a $5.0 million decrease in acquisition and integration
charges related to our strategic collaboration with a healthcare company.
Research and Development
                                Three months ended                  Nine months ended
(dollars in millions)     May 31, 2020       May 31, 2019     May 31, 2020      May 31, 2019
Research and development $       11.6       $      11.4      $       33.6      $      32.7
Percent of net revenue            0.2 %             0.2 %             0.2 %            0.2 %


Research and development expenses remained consistent as a percentage of net
revenue during the three months and nine months ended May 31, 2020, compared to
the three months and nine months ended May 31, 2019.
Amortization of Intangibles
                           Three months ended                                 Nine months ended
(dollars in
millions)            May 31, 2020     May 31, 2019       Change        May 31, 2020        May 31, 2019       Change
Amortization of
intangibles          $      13.2     $         7.6     $    5.6     $      42.9          $         23.0     $   19.9


Amortization of intangibles increased during the three months and nine months
ended May 31, 2020, compared to the three months and nine months ended May 31,
2019, primarily driven by amortization related to the Nypro trade name, which
was reclassified to a definite-lived intangible asset during the fourth quarter
of fiscal year 2019 as a result of our decision to rebrand. As such, this trade
name was assigned a four-year estimated useful life and is being amortized on an
accelerated basis.
Restructuring, Severance and Related Charges
Following is a summary of the Company's restructuring, severance and related
charges (in millions):

                                       32

--------------------------------------------------------------------------------


  Table of Contents

                                         Three months ended                      Nine months ended
                                    May 31,
                                    2020(2)        May 31, 2019(3)     May 31, 2020(2)      May 31, 2019(3)
Employee severance and benefit
costs                            $       56.9     $         6.5       $        83.7        $         15.5
Lease costs                               0.4              (0.1 )               6.9                  (0.1 )
Asset write-off costs                     6.3              (0.3 )              31.7                  (3.5 )
Other costs                               5.6               3.2                21.7                   4.3
Total restructuring, severance
and related charges(1)           $       69.2     $         9.3       $       144.0        $         16.2




(1) Includes $23.7 million and $7.6 million recorded in the EMS segment, $29.3

million and $0.0 million recorded in the DMS segment and $16.2 million and

$1.7 million of non-allocated charges for the three months ended May 31,

2020 and 2019, respectively. Includes $55.8 million and $12.3 million

recorded in the EMS segment, $69.0 million and $2.1 million recorded in the

DMS segment and $19.2 million and $1.8 million of non-allocated charges for

the nine months ended May 31, 2020 and 2019, respectively. Except for asset

write-off costs, all restructuring, severance and related charges are cash

costs.

(2) As the Company continues to optimize its cost structure and improve

operational efficiencies, $52.3 million of employee severance and benefit


      costs was incurred in connection with a reduction in the worldwide
      workforce during the three and nine months ended May 31, 2020. The
      Company's liability associated with the worldwide workforce reduction is

$50.9 million as of May 31, 2020. The remaining amount primarily relates to

the 2020 Restructuring Plan.

(3) Primarily relates to the 2017 Restructuring Plan.




2020 Restructuring Plan
On September 20, 2019, our Board of Directors formally approved a restructuring
plan to realign our global capacity support infrastructure, particularly in our
mobility footprint in China, in order to optimize organizational effectiveness.
This action includes headcount reductions and capacity realignment (the "2020
Restructuring Plan"). The 2020 Restructuring Plan reflects our intention only
and restructuring decisions, and the timing of such decisions, at certain
locations are still subject to consultation with our employees and their
representatives.
We expect to recognize approximately $85.0 million in pre-tax restructuring and
other related costs over the course of our fiscal year 2020. The charges
relating to the 2020 Restructuring Plan are currently expected to result in cash
expenditures in the range of approximately $30.0 million to $40.0 million that
will be payable over the course of our fiscal years 2020 and 2021. The exact
timing of these charges and cash outflows, as well as the estimated cost ranges
by category type, have not been finalized. This information will be subject to
the finalization of timetables for the transition of functions, consultation
with employees and their representatives as well as the statutory severance
requirements of the particular jurisdictions impacted, and the amount and timing
of the actual charges may vary due to a variety of factors. Our estimates for
the charges discussed above exclude any potential income tax effects.
The 2020 Restructuring Plan, once complete, is expected to yield annualized cost
savings beginning in fiscal year 2021 of approximately $40.0 million. We expect
cost savings of $25.0 million during fiscal year 2020.
See Note 13 - "Restructuring, Severance and Related Charges" to the Condensed
Consolidated Financial Statements for further discussion of restructuring,
severance and related charges for the 2020 Restructuring Plan.
Impairment on Securities
                                  Three months ended                                    Nine months ended

(dollars in millions) May 31, 2020 May 31, 2019 Change

     May 31, 2020       May 31, 2019        Change
Impairment on securities $            -     $              -     $       -     $        12.2     $             -     $   12.2


The increase in impairment on securities for the nine months ended May 31, 2020,
compared to the nine months ended May 31, 2019 is due to a non-cash impairment
charge in connection with the sale of an investment in the optical networking
segment during the three months ended February 29, 2020.
Other Expense

                                       33

--------------------------------------------------------------------------------

Table of Contents



                             Three months ended                                Nine months ended
(dollars in millions) May 31, 2020      May 31, 2019      Change        May 31, 2020        May 31, 2019      Change
Other expense         $       5.6     $         14.1     $  (8.5 )   $      25.3          $         39.4     $ (14.1 )


Other expense decreased for the three months ended May 31, 2020, compared to the
three months ended May 31, 2019, primarily due to: (i) $6.4 million related to a
decrease in fees associated with the utilization of the trade accounts
receivable sales programs and (ii) $2.7 million related to lower net periodic
benefit costs. The decrease was partially offset by $0.6 million of other
expense.
Other expense decreased for the nine months ended May 31, 2020, compared to the
nine months ended May 31, 2019, primarily due to: (i) $11.0 million related to a
decrease in fees associated with the utilization of the trade accounts
receivable sales programs and fees incurred for the amendment of the foreign
asset-backed securitization program and the new North American asset-backed
securitization program in fiscal year 2019 and (ii) $7.0 million related to
lower net periodic benefit costs. The decrease was partially offset by $3.9
million of other expense.
Interest Income
                            Three months ended                                Nine months ended
(dollars in millions) May 31, 2020     May 31, 2019      Change        May 31, 2020        May 31, 2019      Change
Interest income       $       1.9     $         6.8     $  (4.9 )   $      13.1          $         15.9     $  (2.8 )


Interest income decreased during the three months ended May 31, 2020, compared
to the three months ended May 31, 2019, primarily due to lower interest rates on
cash equivalents (investments that are readily convertible to cash with maturity
dates of 90 days or less).
Interest income decreased during the nine months ended May 31, 2020, compared to
the nine months ended May 31, 2019, due to lower interest rates, partially
offset by increased cash equivalents (investments that are readily convertible
to cash with maturity dates of 90 days or less).
Interest Expense
                             Three months ended                              Nine months ended
(dollars in millions) May 31, 2020      May 31, 2019      Change       May 31, 2020      May 31, 2019      Change
Interest expense      $      41.9     $         50.5     $  (8.6 )   $     133.0        $       139.3     $  (6.3 )


Interest expense decreased during the three months ended May 31, 2020, compared
to the three months ended May 31, 2019 due to lower interest rates.
Interest expense decreased during the nine months ended May 31, 2020, compared
to the nine months ended May 31, 2019 due to lower interest rates, partially
offset by additional borrowings on our credit facilities and commercial paper
program.
Income Tax Expense
                                Three months ended                           Nine months ended
                          May 31, 2020     May 31, 2019     Change    May

31, 2020      May 31, 2019     Change
Effective income tax rate      465.0 %            47.0 %    418.0 %        108.3 %           32.4 %       75.9 %


The effective income tax rate increased for the three months and nine months
ended May 31, 2020, compared to the three months and nine months ended May 31,
2019, primarily due to: (i) decreased income for the three months and nine
months ended May 31, 2020, driven in part by increased restructuring charges
with minimal related tax benefit; (ii) a $21.2 million income tax expense
associated with the re-measurement of deferred tax assets related to an
extension of a non-U.S. tax incentive recorded during the three months ended May
31, 2020; and (iii) adjustments related to the Tax Cuts and Jobs Act of 2017
(the "Tax Act") for the nine months ended May 31, 2019, including a $13.3
million income tax benefit recorded during the three months ended November 30,
2018.


                                       34

--------------------------------------------------------------------------------

Table of Contents



Non-GAAP (Core) Financial Measures
The following discussion and analysis of our financial condition and results of
operations include certain non-GAAP financial measures as identified in the
reconciliations below. The non-GAAP financial measures disclosed herein do not
have standard meaning and may vary from the non-GAAP financial measures used by
other companies or how we may calculate those measures in other instances from
time to time. Non-GAAP financial measures should not be considered a substitute
for, or superior to, measures of financial performance prepared in accordance
with U.S. GAAP. Also, our "core" financial measures should not be construed as
an indication by us that our future results will be unaffected by those items
that are excluded from our "core" financial measures.
Management believes that the non-GAAP "core" financial measures set forth below
are useful to facilitate evaluating the past and future performance of our
ongoing manufacturing operations over multiple periods on a comparable basis by
excluding the effects of the amortization of intangibles, stock-based
compensation expense and related charges, restructuring, severance and related
charges, distressed customer charges, acquisition and integration charges, loss
on disposal of subsidiaries, settlement of receivables and related charges,
impairment of notes receivable and related charges, goodwill impairment charges,
business interruption and impairment charges, net, impairment on securities,
restructuring of securities loss, income (loss) from discontinued operations,
gain (loss) on sale of discontinued operations and certain other expenses, net
of tax and certain deferred tax valuation allowance charges. Among other uses,
management uses non-GAAP "core" financial measures to make operating decisions,
assess business performance and as a factor in determining certain employee
performance when evaluating incentive compensation.
We determine the tax effect of the items excluded from "core" earnings and
"core" diluted earnings per share based upon evaluation of the statutory tax
treatment and the applicable tax rate of the jurisdiction in which the pre-tax
items were incurred, and for which realization of the resulting tax benefit, if
any, is expected. In certain jurisdictions where we do not expect to realize a
tax benefit (due to existing tax incentives or a history of operating losses or
other factors resulting in a valuation allowance related to deferred tax
assets), a reduced or 0% tax rate is applied.
We are reporting "core" operating income, "core" earnings and adjusted free cash
flow to provide investors with an additional method for assessing operating
income and earnings, by presenting what we believe are our "core" manufacturing
operations. A significant portion (based on the respective values) of the items
that are excluded for purposes of calculating "core" operating income and "core"
earnings also impacted certain balance sheet assets, resulting in a portion of
an asset being written off without a corresponding recovery of cash we may have
previously spent with respect to the asset. In the case of restructuring,
severance and related charges, we may make associated cash payments in the
future. In addition, although, for purposes of calculating "core" operating
income and "core" earnings, we exclude stock-based compensation expense (which
we anticipate continuing to incur in the future) because it is a non-cash
expense, the associated stock issued may result in an increase in our
outstanding shares of stock, which may result in the dilution of our
stockholders' ownership interest. We encourage you to consider these matters
when evaluating the utility of these non-GAAP financial measures.
Adjusted free cash flow is defined as net cash provided by (used in) operating
activities plus cash receipts on sold receivables less net capital expenditures
(acquisition of property, plant and equipment less proceeds and advances from
the sale of property, plant and equipment). We report adjusted free cash flow as
we believe this non-GAAP financial measure is useful to investors in measuring
our ability to generate cash internally and fund future growth and to provide a
return to shareholders.
Included in the tables below are reconciliations of the non-GAAP financial
measures to the most directly comparable U.S. GAAP financial measures as
provided in our Condensed Consolidated Financial Statements:
Reconciliation of U.S. GAAP Financial Results to Non-GAAP Measures

                                       35

--------------------------------------------------------------------------------


  Table of Contents

                                         Three months ended                   Nine months ended
(in thousands, except for per
share data)                       May 31, 2020       May 31, 2019      May 31, 2020      May 31, 2019
Operating income (U.S. GAAP)     $      59,384     $      140,918     $     302,793     $     511,611
Amortization of intangibles             13,178              7,610            42,895            23,033
Stock-based compensation expense
and related charges                     16,882             14,506            62,214            47,452
Restructuring, severance and
related charges (1)                     69,150              9,340           144,005            16,182
Distressed customer charge (2)               -                  -            14,963                 -
Net periodic benefit cost (3)            2,797                  -             7,398                 -
Business interruption and
impairment charges, net (4)              4,574                  -             4,574            (2,860 )
Acquisition and integration
charges (5)                              6,119             13,391            30,005            35,066
Adjustments to operating income        112,700             44,847           306,054           118,873
Core operating income (Non-GAAP) $     172,084     $      185,765     $     608,847     $     630,484
Net (loss) income attributable
to Jabil Inc. (U.S. GAAP)        $     (50,958 )   $       43,482     $     (13,819 )   $     234,436
Adjustments to operating income        112,700             44,847           306,054           118,873
Impairment on securities                     -                  -            12,205                 -
Net periodic benefit cost (3)           (2,797 )                -            (7,398 )               -
Adjustments for taxes (6)               (2,422 )              125             1,166           (17,837 )
Core earnings (Non-GAAP)         $      56,523     $       88,454     $     298,208     $     335,472
Diluted (loss) earnings per
share (U.S. GAAP)                $       (0.34 )   $         0.28     $       (0.09 )   $        1.47
Diluted core earnings per share
(Non-GAAP)                       $        0.37     $         0.57     $        1.93     $        2.11
Diluted weighted average shares
outstanding (U.S. GAAP)                150,723            155,678           151,956           159,036
Diluted weighted average shares
outstanding (Non-GAAP)                 152,693            155,678           154,412           159,036





(1)   As the Company continues to optimize its cost structure and improve

operational efficiencies, $52.3 million of employee severance and benefit


      costs was incurred in connection with a reduction in the worldwide
      workforce during the three and nine months ended May 31, 2020.

(2) Charges relate to accounts receivable and inventory charges for certain

distressed customers primarily in the renewable energy sector.

(3) Following the adoption of Accounting Standards Update 2017-07, Compensation

- Retirement Benefits (Topic 715) ("ASU 2017-07"), pension service cost is

recognized in cost of revenue and all other components of net periodic

benefit cost, including return on plan assets, are presented in other

expense. We are reclassifying the pension components in other expense to

core operating income as we assess operating performance, inclusive of all

components of net periodic benefit cost, with the related revenue. There is

no impact to core earnings or diluted core earnings per share for this

adjustment.

(4) Charges for the three and nine months ended May 31, 2020, relate to a flood

that impacted our facility in Huangpu, China. Charges, net of insurance

proceeds of $2.9 million for the nine months ended May 31, 2019, relate to

business interruptions and asset impairment costs associated with damage

from Hurricane Maria, which impacted our operations in Cayey, Puerto Rico.




(5)   Charges related to our strategic collaboration with Johnson & Johnson
      Medical Devices Companies ("JJMD").


(6)   The nine months ended May 31, 2019 includes a $13.3 million income tax

benefit for the effects of the Tax Act recorded during the three months

ended November 30, 2018.





Adjusted Free Cash Flow

                                       36

--------------------------------------------------------------------------------


  Table of Contents

                                                               Nine months ended
 (in thousands)                                         May 31, 2020      May 31, 2019(1)
Net cash provided by operating activities (U.S. GAAP) $      570,726     $  

112,656


Cash receipts on sold receivables                                  -        

96,846


Acquisition of property, plant and equipment                (648,945 )      

(789,226 ) Proceeds and advances from sale of property, plant and equipment

                                                 93,679        

167,653


Adjusted free cash flow (Non-GAAP)                    $       15,460     $      (412,071 )

(1) In fiscal year 2019, the adoption of Accounting Standards Update ("ASU")

2016-15, "Classification of Certain Cash Receipts and Cash Payments"

resulted in a reclassification of cash flows from operating activities to

investing activities for cash receipts for the deferred purchase price


       receivable on asset-backed securitization transactions. The adoption of
       this standard does not reflect a change in the underlying business or

activities. The effects of this change are applied retrospectively to all


       prior periods.



Acquisitions and Expansion
During fiscal year 2018, the Company and Johnson & Johnson Medical Devices
Companies ("JJMD") entered into a Framework Agreement to form a strategic
collaboration and expand our existing relationship. The strategic collaboration
expands our medical device manufacturing portfolio, diversification and
capabilities.
On February 25, 2019 and April 29, 2019, under the terms of the Framework
Agreement, we completed the initial and second closings, respectively, of our
acquisition of certain assets of JJMD. The aggregate purchase price paid for the
initial and second closings was approximately $167.4 million in cash. For the
initial and second closings, total assets acquired of $173.5 million and total
liabilities assumed of $6.1 million were recorded at their estimated fair values
as of the acquisition dates.
On September 30, 2019, under the terms of the Framework Agreement, we completed
the third closing of our acquisition of certain assets of JJMD. The preliminary
aggregate purchase price paid for the third closing was approximately $111.8
million in cash, which remains subject to certain post-closing adjustments based
on conditions within the Framework Agreement. For the third closing, total
assets acquired of $199.7 million, including $83.2 million in contract assets,
$35.1 million in inventory and $70.4 million in goodwill, and total liabilities
assumed of $87.9 million, including $73.5 million of pension obligations, were
recorded at their estimated fair values as of the acquisition date. There were
no intangible assets identified in this acquisition and the goodwill is
primarily attributable to the assembled workforce. The majority of the goodwill
is currently not expected to be deductible for income tax purposes.
The acquisition of the JJMD assets have been accounted for as separate business
combinations for each closing using the acquisition method of accounting. We are
currently evaluating the fair values of the assets and liabilities related to
the third closing of these business combinations. The preliminary estimates and
measurements are, therefore, subject to change during the measurement period for
assets acquired, liabilities assumed and tax adjustments. The results of
operations were included in our consolidated financial results beginning on
February 25, 2019 for the initial closing, April 29, 2019 for the second closing
and September 30, 2019 for the third closing. We believe it is impracticable to
provide pro forma information for the acquisition of the JJMD assets.

Liquidity and Capital Resources
We believe that our level of liquidity sources, which includes available
borrowings under our revolving credit facilities and commercial paper program,
additional proceeds available under our asset-backed securitization programs and
under our uncommitted trade accounts receivable sale programs, cash on hand,
funds provided by operations and the access to the capital markets, will be
adequate to fund our capital expenditures, the payment of any declared quarterly
dividends, any share repurchases under the approved program, any potential
acquisitions and our working capital requirements for the next 12 months. We
continue to assess our capital structure and evaluate the merits of redeploying
available cash.
Certain of our trade accounts receivable sale programs expire or are subject to
termination provisions within the 2020 calendar year. In addition, our 5.625%
Senior Notes mature on December 15, 2020. While we expect to renew such trade
accounts receivable sale programs and refinance our Senior Notes, market
conditions, including the implications of the COVID-19 pandemic, at the time our
current programs expire and debt matures, respectively, may create challenges in
doing so, such as incurring a higher cost of capital.


                                       37

--------------------------------------------------------------------------------

Table of Contents



Cash and Cash Equivalents
As of May 31, 2020, we had approximately $763.3 million in cash and cash
equivalents. As our growth remains predominantly outside of the United States, a
significant portion of such cash and cash equivalents are held by our foreign
subsidiaries. Most of our cash and cash equivalents as of May 31, 2020 could be
repatriated to the United States without potential tax consequences.
Notes Payable and Credit Facilities
Following is a summary of principal debt payments and debt issuance for our
notes payable and credit facilities:
                                                                                                                             Borrowings                                                                       Total notes
                                                                                                                               under                                                                            payable
                      5.625%              4.700%              4.900%              3.950%                                     revolving                         Borrowings                  Borrowings             and
                      Senior              Senior              Senior              Senior         3.600% Senior                 credit                             under                      under              credit
(in thousands)         Notes               Notes               Notes               Notes           Notes(1)             facilities(2)(3)(4)            commercial paper program(4)          loans(2)          facilities
Balance as of
August 31, 2019  $       398,886     $       498,004     $       299,057     $       494,825     $         -     $                        -           $                 -             $          805,693     $ 2,496,465
Borrowings                     -                   -                   -                   -         499,165                      8,485,027                       237,661                        300,000       9,521,853
Payments                       -                   -                   -                   -               -                     (8,485,027 )                    (237,661 )                     (806,383 )    (9,529,071 )
Other                        669                 492                 182                 461          (4,549 )                            -                             -                            828          (1,917 )
Balance as of
May 31, 2020     $       399,555     $       498,496     $       299,239     $       495,286     $   494,616     $                        -           $                 -             $          300,138     $ 2,487,330
                                                                                                                 Apr 23, 2021, Jan 22, 2023 and Jan
Maturity Date    Dec 15, 2020        Sep 15, 2022        Jul 14, 2023        Jan 12, 2028        Jan 15, 2030    22, 2025(2)(3)(4)                                (4)                 Jan 22, 2025(2)
Original
Facility/                                                                                           $500.0

Maximum Capacity $400.0 million $500.0 million $300.0 million

  $500.0 million        million            $3.7 billion(2)(3)(4)                      (4)                  $301.7 million(2)




(1) On January 15, 2020, we issued $500.0 million of publicly registered 3.600%


      Senior Notes due 2030 (the "3.600% Senior Notes"). The net proceeds from
      the offering were used for the repayment of term loan indebtedness.

(2) On January 22, 2020, we entered into a senior unsecured credit agreement

which provides for: (i) a Revolving Credit Facility in the initial amount


      of $2.7 billion, of which $700.0 million expires on January 22, 2023 and
      $2.0 billion expires on January 22, 2025 and (ii) a $300.0 million Term

Loan Facility which expires on January 22, 2025, (collectively the "Credit

Facility"). Interest and fees on the Credit Facility advances are based on

our non-credit enhanced long-term senior unsecured debt rating as

determined by Standard & Poor's Ratings Service, Moody's Investors Service

and Fitch Ratings. In connection with our entry into the Credit Facility,

we terminated our amended and restated five-year credit agreement dated

November 8, 2017 and the credit agreement dated August 24, 2018.





During the nine months ended May 31, 2020, the interest rates on the Revolving
Credit Facility ranged from 1.2% to 4.3% and the Term Loan Facility ranged from
1.6% to 3.5%. Interest is charged at a rate equal to (a) for the Revolving
Credit Facility, either 0.000% to 0.450% above the base rate or 0.975% to 1.450%
above the Eurocurrency rate and (b) for the Term Loan Facility, either 0.125% to
0.750% above the base rate or 1.125% to 1.750% above the Eurocurrency rate. The
base rate represents the greatest of: (i) Citibank, N.A.'s prime rate,
(ii) 0.50% above the federal funds rate, and (iii) 1.0% above one-month LIBOR,
but not less than zero. The Eurocurrency rate represents adjusted LIBOR or
adjusted CDOR, as applicable, for the applicable interest period, but not less
than zero. Fees include a facility fee based on the revolving credit commitments
of the lenders and a letter of credit fee based on the amount of outstanding
letters of credit.
(3)   On April 24, 2020, we entered into an unsecured 364-day revolving credit

agreement up to an initial aggregate amount of $375.0 million, which was

increased to $425.0 million on May 29, 2020 (the "364-Day Revolving Credit

Agreement"). The 364-Day Revolving Credit Agreement expires on April 23,

2021. Interest and fees on the 364-Day Revolving Credit Agreement advances

are based on our non-credit enhanced long-term senior unsecured debt rating


      as determined by Standard & Poor's Ratings Service, Moody's Investors
      Service and Fitch Ratings.



                                       38

--------------------------------------------------------------------------------

Table of Contents




As of May 31, 2020, no draws were made on the 364-Day Revolving Credit
Agreement. Interest is charged at a rate equal to either (i) 0.450%, 0.525% or
0.800% above the base rate or (ii) 1.450%, 1.525% or 1.800% above the Eurodollar
rate. The base rate represents the greatest of: (i) Mizuho's base rate,
(ii) 0.50% above the federal funds rate, and (iii) 1.0% above one-month LIBOR,
subject to a floor of 0.75%. The Eurodollar rate represents adjusted LIBOR for
the applicable interest period, subject to a floor of 0.75%. Fees include a
facility fee based on the revolving credit commitments of the lenders.
(4)   As of May 31, 2020, we had $3.7 billion in available unused borrowing

capacity under our revolving credit facilities. The Revolving Credit

Facility under the Credit Facility acts as the back-up facility for

commercial paper outstanding, if any. We have a borrowing capacity of up to

$1.8 billion under our commercial paper program.




We have a shelf registration statement with the SEC registering the potential
sale of an indeterminate amount of debt and equity securities in the future to
augment our liquidity and capital resources.
Our Senior Notes and our credit facilities contain various financial and
nonfinancial covenants. A violation of these covenants could negatively impact
our liquidity by restricting our ability to borrow under the notes payable and
credit facilities and potentially causing acceleration of amounts due under
these notes payable and credit facilities. As of May 31, 2020, we were in
compliance with our debt covenants. Refer to Note 5 - "Notes Payable and
Long-Term Debt" to the Condensed Consolidated Financial Statements for further
details.
Asset-Backed Securitization Programs
We continuously sell designated pools of trade accounts receivable, at a
discount, under our foreign asset-backed securitization program and our North
American asset-backed securitization program to special purpose entities, which
in turn sell certain of the foreign asset-backed receivables to an unaffiliated
financial institution and a conduit administered by an unaffiliated financial
institution and certain of the North American asset-backed receivables to
conduits administered by an unaffiliated financial institution on a monthly
basis.
The foreign asset-backed securitization program contains a guarantee of payment
by the special purpose entity, in an amount approximately equal to the net cash
proceeds under the program. No liability has been recorded for obligations under
the guarantee as of May 31, 2020.
Certain unsold receivables covering the maximum amount of net cash proceeds
available under the North American asset-backed securitization program are
pledged as collateral to the unaffiliated financial institution as of May 31,
2020.
Following is a summary of our asset-backed securitization programs and key
terms:

                         Maximum Amount of                 Expiration
                Net Cash Proceeds (in millions)(1)            Date
North American $                              390.0    November 22, 2021
Foreign        $                              400.0    September 30, 2021





(1)  Maximum amount available at any one time.


In connection with our asset-backed securitization programs, during the three
months and nine months ended May 31, 2020, we sold $0.9 billion and $3.2
billion, respectively, of trade accounts receivable and we received cash
proceeds of $0.9 billion and $3.2 billion, respectively. As of May 31, 2020, we
had up to $136.6 million in available liquidity under our asset-backed
securitization programs.
Our asset-backed securitization programs contain various financial and
nonfinancial covenants. As of May 31, 2020 and August 31, 2019, we were in
compliance with all covenants under our asset-backed securitization programs.
Refer to Note 6 - "Asset-Backed Securitization Programs" to the Condensed
Consolidated Financial Statements for further details on the programs.
Trade Accounts Receivable Sale Programs

                                       39

--------------------------------------------------------------------------------

Table of Contents



Following is a summary of the trade accounts receivable sale programs with
unaffiliated financial institutions. Under the programs we may elect to sell
receivables and the unaffiliated financial institutions may elect to purchase,
at a discount, on an ongoing basis:
               Maximum
               Amount                Type of          Expiration
Program   (in millions)(1)          Facility             Date
A        $            600.0        Uncommitted   December 5, 2020(2)
B        $            150.0        Uncommitted   November 30, 2020(3)
C                     800.0  CNY   Uncommitted   June 30, 2020
D        $            150.0        Uncommitted   May 4, 2023(4)
E        $             50.0        Uncommitted   August 25, 2020
F        $            150.0        Uncommitted   January 25, 2021(5)
G        $             50.0        Uncommitted   February 23, 2023(6)
H        $            100.0        Uncommitted   August 10, 2020(7)
I        $            100.0        Uncommitted   July 21, 2020(8)
J        $            650.0        Uncommitted   December 4, 2020(9)
K        $            135.0        Uncommitted   April 11, 2021(10)
L                     100.0  CHF   Uncommitted   December 5, 2020(2)




(1) Maximum amount of trade accounts receivable that may be sold under a

facility at any one time.

(2) The program will be automatically extended each year through December 5,

2025 unless either party provides 30 days notice of termination.

(3) The program will automatically extend for one year at each expiration date

unless either party provides 10 days notice of termination.

(4) Any party may elect to terminate the agreement upon 30 days prior notice.

(5) The program will be automatically extended through January 25, 2023 unless

either party provides 30 days notice of termination.

(6) Any party may elect to terminate the agreement upon 15 days prior notice.

(7) The program will be automatically extended through August 10, 2023 unless

either party provides 30 days notice of termination.

(8) The program will be automatically extended through August 21, 2023 unless


      either party provides 30 days notice of termination.


(9)   The program will be automatically extended each year through December 5,
      2024 unless either party provides 30 days notice of termination.

(10) The program will be automatically extended each year through April 11, 2025

unless either party provides 30 days notice of termination.




During the three months and nine months ended May 31, 2020, we sold $2.2 billion
and $6.3 billion, respectively, of trade accounts receivable under these
programs and we received cash proceeds of $2.2 billion and $6.3 billion,
respectively. As of May 31, 2020, we had up to $932.4 million in available
liquidity under our trade accounts receivable sale programs.
Capital Expenditures
For Fiscal Year 2020, we anticipate our net capital expenditures will be
approximately $800.0 million. In general, our capital expenditures support
ongoing maintenance in our DMS and EMS segments and investments in new markets.
The amount of actual capital expenditures may be affected by general economic,
financial, competitive, legislative and regulatory factors, among other things.
Cash Flows
The following table sets forth selected consolidated cash flow information (in
thousands):

                                       40

--------------------------------------------------------------------------------


  Table of Contents

                                                               Nine months ended
                                                        May 31, 2020       May 31, 2019
Net cash provided by operating activities             $      570,726     $  

112,656


Net cash used in investing activities                       (679,463 )         (704,095 )
Net cash (used in) provided by financing activities         (259,592 )      

19,909


Effect of exchange rate changes on cash and cash
equivalents                                                  (31,677 )      

7,667


Net decrease in cash and cash equivalents             $     (400,006 )   $  

(563,863 )




Operating Activities
Net cash provided by operating activities during the nine months ended May 31,
2020 was primarily due to non-cash expenses, decreased accounts receivable and
increased accounts payable, accrued expenses and other liabilities, partially
offset by increased contract assets, inventories and prepaid expenses and other
current assets. The decrease in accounts receivable is primarily driven by the
timing of collections. The increase in accounts payable, accrued expenses and
other liabilities is primarily due to the timing of purchases and cash payments.
The increase in contract assets is primarily due to the timing of revenue
recognition for over time customers. The increase in inventories is primarily to
support expected sales levels in the fourth quarter of fiscal year 2020. The
increase in prepaid expenses and other current assets is primarily due to an
increase in value added tax receivables.
Investing Activities
Net cash used in investing activities during the nine months ended May 31, 2020
consisted primarily of capital expenditures principally to support ongoing
business in the DMS and EMS segments and expenditures for assets acquired in
connection with the third closing of the acquisition of certain assets of JJMD,
partially offset by proceeds and advances from the sale of property, plant and
equipment.
Financing Activities
Net cash used in financing activities during the nine months ended May 31, 2020
was primarily due to (i) payments for debt agreements, (ii) the repurchase of
our common stock, (iii) dividend payments and (iv) treasury stock minimum tax
withholding related to vesting of restricted stock. Net cash used in financing
activities was partially offset by (i) borrowings under debt agreements and (ii)
net proceeds from the exercise of stock options and issuance of common stock
under the employee stock purchase plan.
Contractual Obligations
As of the date of this report, other than the borrowings on the 3.600% Senior
Notes, the Credit Facility and the 364-Day Revolving Credit Agreement (see Note
5 - "Notes Payable and Long-Term Debt" to the Condensed Consolidated Financial
Statements) and the items disclosed below, there were no material changes
outside the ordinary course of business since August 31, 2019 to
our contractual obligations and commitments.
In connection with the third closing of the acquisition of certain assets of
JJMD, we assumed additional contractual obligations related to postretirement
benefit plans and executed certain financing leases. The following table
provides details of these assumed obligations:
                                                            Payments due by period (in thousands)
                                                         Less than 1                                       After 5
                                            Total           year           1-3 years       3-5 years        years
Pension and postretirement contributions
and payments(1)                          $  11,026     $      11,026     $         -     $         -     $       -
Finance lease obligations(2)             $ 114,275     $       5,904     $    12,972     $    13,102     $  82,297

(1) Represents the estimated company contributions to the funded Switzerland

plan during fiscal year 2020. These future payments are not recorded on

the Condensed Consolidated Balance Sheets but will be recorded as

incurred. Refer to Note 8 - Postretirement and other Employee Benefits for

further discussion of the assumed postretirement benefit obligation.

(2) The amount payable after five years includes $75.1 million in purchase


       requirements at the end of the respective leases.



                                       41

--------------------------------------------------------------------------------

Table of Contents



Dividends and Share Repurchases
We currently expect to continue to declare and pay regular quarterly dividends
of an amount similar to our past declarations. However, the declaration and
payment of future dividends are discretionary and will be subject to
determination by our Board of Directors each quarter following its review of our
financial performance and global economic conditions.
In September 2019, the Board of Directors authorized the repurchase of up to
$600.0 million of our common stock as a part of a two-year capital allocation
framework (the "2020 Share Repurchase Program"). As of May 31, 2020, 5.2 million
shares had been repurchased for $188.9 million and $411.1 million remains
available under the 2020 Share Repurchase Program.

                                       42

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses